524218 Stock Overview
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Resonance Specialties Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹126.30 |
| 52 Week High | ₹133.45 |
| 52 Week Low | ₹77.00 |
| Beta | 0.97 |
| 1 Month Change | 36.76% |
| 3 Month Change | 20.63% |
| 1 Year Change | 50.12% |
| 3 Year Change | -11.15% |
| 5 Year Change | 460.09% |
| Change since IPO | 8,320.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524218 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 5.7% | 1.9% | 1.4% |
| 1Y | 50.1% | 18.9% | 46.1% |
Return vs Industry: 524218 exceeded the Indian Chemicals industry which returned 16.5% over the past year.
Return vs Market: 524218 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
| 524218 volatility | |
|---|---|
| 524218 Average Weekly Movement | 7.8% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 524218's share price has been volatile over the past 3 months.
Volatility Over Time: 524218's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 67 | Charchit Jain | www.resonancesl.com |
Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, and niacinamide; alpha picolinic and dipicolinic acids; solvents, including acetonitrile and valeronitrile; lutidines for anti-ulcer drugs; and collidines for omeprazole and other pharmaceutical products.
Resonance Specialties Limited Fundamentals Summary
| 524218 fundamental statistics | |
|---|---|
| Market cap | ₹1.46b |
| Earnings (TTM) | ₹35.36m |
| Revenue (TTM) | ₹573.22m |
41.2x
P/E Ratio2.5x
P/S RatioIs 524218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524218 income statement (TTM) | |
|---|---|
| Revenue | ₹573.22m |
| Cost of Revenue | ₹350.73m |
| Gross Profit | ₹222.48m |
| Other Expenses | ₹187.12m |
| Earnings | ₹35.36m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.06 |
| Gross Margin | 38.81% |
| Net Profit Margin | 6.17% |
| Debt/Equity Ratio | 5.8% |
How did 524218 perform over the long term?
See historical performance and comparison